Clinical Trials Insight: 700039719
Phase of Trial: Phase I
Latest Information Update: 15 Dec 2009
At a glance
- Drugs Caplacizumab (Primary)
- Indications Thrombosis; Thrombotic thrombocytopenic purpura
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Ablynx
- 15 Dec 2009 Results presented at the 51st Annual Meeting and Exposition of the American Society of Hematology (ASH 2009).
- 19 Aug 2009 Status changed from recruiting to completed, based on results reported in media release.
- 18 Aug 2009 Positive results data have been reported in an Ablynx media release.